Thus, some treatment effects in the preventive studies might be due to interfering with homeostatic expansion, which is not relevant in IBD and conversely, a test compound's effect on B and CD8+ T cells will have no effect in the model, although it might be effective in IBD. Here, CD8A is linked to inflammatory bowel disease.